• FDA authorizes Regeneron antibody cocktail for post-exposure prophylaxis of COVID-19

    1 month ago - By Healio

    Following the June update that allowed for a lower dose of Regeneron's antibody cocktail to treat COVID-19, the FDA has again expanded emergency use authorization, this time allowing for its use as post-exposure prophylaxis.
    According to a press release from Regeneron, the update enables individuals who have already been exposed to SARS-CoV-2, along with those who are at high risk of being exposed due to residing in an institutional setting , to receive the cocktail.
    "Today's FDA authorization enables certain people at high risk of developing severe COVID-19
    Read more ...

     

  • FDA OKs emergency use of baricitinib alone for COVID-19

    FDA OKs emergency use of baricitinib alone for COVID-19

    1 month ago - By Healio

    The FDA has authorized emergency use of baricitinib alone for the treatment of patients aged 2 years and older who are hospitalized with COVID-19.
    The authorization applies to infected patients who require supplemental oxygen, mechanical ventilation or extracorporeal membrane oxygenation, according to a press release from the FDA. This is an update to the agency's previous emergency use authorization, which mandated that baricitinib be administered in conjunction with remdesivir .
    “Baricitinib in combination with remdesivir
    Read more ...